{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:06:52Z","timestamp":1791446812363,"version":"4.3.3"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T00:00:00Z","timestamp":1580428800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T00:00:00Z","timestamp":1580428800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s11239-020-02046-2","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T03:02:35Z","timestamp":1580439755000},"page":"475-479","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Rivaroxaban in patients undergoing surgical mitral valve repair"],"prefix":"10.1007","volume":"49","author":[{"given":"Feridoun","family":"Noohi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parham","family":"Sadeghipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirous","family":"Kordrostami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Shafe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Maleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Kyavar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hooman","family":"Bakhshandeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrad","family":"Rokni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamal","family":"Moosavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Tashakori Beheshti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,31]]},"reference":[{"issue":"4","key":"2046_CR1","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.jtcvs.2018.08.091","volume":"157","author":"EL Hannan","year":"2019","unstructured":"Hannan EL, Samadashvili Z, Smith CR, Lahey SJ, Gold JP, Jordan D et al (2019) Mitral valve repair versus replacement for patients with preserved left ventricular function without heart failure symptoms. J Thorac Cardiovasc Surg 157(4):1432\u20139.e2","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"36","key":"2046_CR2","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","volume":"38","author":"H Baumgartner","year":"2017","unstructured":"Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ et al (2017) 2017 ESC\/EACTS guidelines for the management of valvular heart disease. Eur Heart J 38(36):2739\u20132791","journal-title":"Eur Heart J"},{"issue":"6","key":"2046_CR3","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1510\/icvts.2006.143099","volume":"5","author":"S Asopa","year":"2006","unstructured":"Asopa S, Patel A, Dunning J (2006) Is short-term anticoagulation necessary after mitral valve repair? Interact Cardiovasc Thorac Surg 5(6):761\u2013765","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"11","key":"2046_CR4","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.jacc.2016.12.031","volume":"69","author":"R De Caterina","year":"2017","unstructured":"De Caterina R, Renda G, Carnicelli AP, Nordio F, Trevisan M, Mercuri MF et al (2017) Valvular heart disease patients on edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial. J Am Coll Cardiol 69(11):1372\u20131382","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"2046_CR5","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1161\/CIRCULATIONAHA.116.026714","volume":"135","author":"AP Carnicelli","year":"2017","unstructured":"Carnicelli AP, De Caterina R, Halperin JL, Renda G, Ruff CT, Trevisan M et al (2017) Edoxaban for the prevention of thromboembolism in patients with atrial fibrillation and bioprosthetic valves. Circulation 135(13):1273\u20131275","journal-title":"Circulation"},{"issue":"5","key":"2046_CR6","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/clc.23178","volume":"42","author":"PO Guimaraes","year":"2019","unstructured":"Guimaraes PO, Pokorney SD, Lopes RD (2019) Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: insights from the ARISTOTLE trial. Clin Cardiol 42(5):568\u2013571","journal-title":"Clin Cardiol"},{"issue":"8","key":"2046_CR7","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1161\/CIRCULATIONAHA.115.020950","volume":"134","author":"MD Ezekowitz","year":"2016","unstructured":"Ezekowitz MD, Nagarakanti R, Noack H, Brueckmann M, Litherland C, Jacobs M et al (2016) Comparison of dabigatran and warfarin in patients with atrial fibrillation and valvular heart disease: the RE-LY trial (randomized evaluation of long-term anticoagulant therapy). Circulation 134(8):589\u2013598","journal-title":"Circulation"},{"issue":"11","key":"2046_CR8","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.jacc.2016.12.038","volume":"69","author":"G Renda","year":"2017","unstructured":"Renda G, Ricci F, Giugliano RP, De Caterina R (2017) Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease. J Am Coll Cardiol 69(11):1363\u20131371","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"2046_CR9","doi-asserted-by":"publisher","first-page":"e006475","DOI":"10.1161\/JAHA.117.006475","volume":"6","author":"KL Thomas","year":"2017","unstructured":"Thomas KL, Jackson LR 2nd, Shrader P, Ansell J, Fonarow GC, Gersh B et al (2017) Prevalence, characteristics, and outcomes of valvular heart disease in patients with atrial fibrillation: insights from the ORBIT-AF (outcomes registry for better informed treatment for atrial fibrillation). J Am Heart Assoc 6(12):e006475","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"2046_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/jth.13883","volume":"16","author":"MR Fasulo","year":"2018","unstructured":"Fasulo MR, Biguzzi E, Abbattista M, Stufano F (2018) The ISTH bleeding assessment tool and the risk of future bleeding. J Thromb Haemost 16(1):125\u2013130","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2046_CR11","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jacc.2017.03.011","volume":"70","author":"RA Nishimura","year":"2017","unstructured":"Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA et al (2017) 2017 AHA\/ACC Focused Update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American college of cardiology\/american heart association task force on clinical practice guidelines. J Am Coll Cardiol 70(2):252\u2013289","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2046_CR12","first-page":"576","volume":"14","author":"P Vaughan","year":"2005","unstructured":"Vaughan P, Waterworth PD (2005) An audit of anticoagulation practice among UK cardiothoracic consultant surgeons following valve replacement\/repair. J Heart Valve Dis 14(5):576\u2013582","journal-title":"J Heart Valve Dis"},{"issue":"9","key":"2046_CR13","first-page":"687","volume":"102","author":"N Valeur","year":"2016","unstructured":"Valeur N, Merie C, Hansen ML, Torp-Pedersen C, Gislason GH, Kober L (2016) Risk of death and stroke associated with anticoagulation therapy after mitral valve repair. Heart (British Cardiac Society) 102(9):687\u2013693","journal-title":"Heart (British Cardiac Society)"},{"issue":"4","key":"2046_CR14","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1055\/s-0037-1615261","volume":"44","author":"V Russo","year":"2018","unstructured":"Russo V, Attena E, Mazzone C, Esposito F, Parisi V, Bancone C et al (2018) Nonvitamin K antagonist oral anticoagulants use in patients with atrial fibrillation and bioprosthetic heart valves\/prior surgical valve repair: a multicenter clinical practice experience. Semin Thromb Hemost 44(4):364\u2013369","journal-title":"Semin Thromb Hemost"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02046-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-020-02046-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02046-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T00:43:00Z","timestamp":1611967380000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-020-02046-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,31]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["2046"],"URL":"https:\/\/doi.org\/10.1007\/s11239-020-02046-2","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,31]]},"assertion":[{"value":"31 January 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}